February 25, 2019
FDA: Class I recall of ICU Medical’s ChemoLock Vial Spike
Editor's Note
The Food & Drug Administration (FDA) on February 22 identified the recall by ICU Medical (San Clemente, California) of its ChemoLock Vial Spike (20 mm) as Class I, the most serious.
The recall was initiated because of the potential for plastic particles to break off the protective cap. The plastic particles could be infused into a patient’s IV line, which could lead to embolism, serious injury, or death.
The Lot Number is 3757712. Distribution dates are August 2018 to September 2018.
Free Daily News
- GAO urges HHS to strengthen cybersecurity oversight
- Study: GLP-1s reduce TKA complications for non-diabetic patients with obesity
- Study finds high rates of preventable, adverse events in perioperative care
- AMA urges stronger radiation protections
- Study: Digital tool detects preoperative pediatric anxiety, depression
- Hospital safety grades show progress in reducing medical errors, infections
- Analysis: Overuse of back surgeries costs Medicare $2 billion, risks patient safety
- AI-powered surgical robot learns by watching
- AHA's Congressional "wish list" calls for financial relief, patient access, workforce protections
- Out-of-hospital cardiac arrest survival rates lag pre-pandemic levels, racial disparities persist
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement